• posted: Jan. 08, 2021
• Nass Cancelliere Nass
• Asbestos
• European Journal of Cancer,  Keytruda,  Opdivo,  statins

A study conducted at Universita Politecnica delle Marche in Ancona, Italy reported that treatment with drugs such as Opdivo and Keytruda –– considered a major breakthrough in recent years –– Read More

• posted: Dec. 16, 2020
• Nass Cancelliere Nass
• Mesothelioma,  Asbestos
• CancerCare

Finances can become the deciding factor in which treatment a patient with cancer chooses to receive, where they receive it and if they can keep on that treatment regimen for Read More

• posted: Dec. 11, 2020
• Nass Cancelliere Nass
• Asbestos
• nanotubes

Gold nanotubes -- tiny hollow cylinders one thousandth the width of a human hair -- could be used to treat mesothelioma, a type of cancer caused by exposure to asbestos, Read More

• posted: Dec. 07, 2020
• Nass Cancelliere Nass
• Asbestos
• asbestos law firm

Evidence that a company protected its own workers from asbestos while undertaking no steps to investigate or prevent consumer exposures shows malice sufficient for punitive damages, and a trial court Read More

• posted: Nov. 20, 2020
• Nass Cancelliere Nass
• Mesothelioma,  Asbestos
• FDA approvals,  malignant pleural mesothelioma

Last month, the U.S. Food and Drug Administration approved Opdivo (nivolumab) in combination with Yervoy (ipilimumab) for the first-line treatment of adults with malignant pleural mesothelioma that cannot be removed Read More

• posted: Nov. 12, 2020
• Nass Cancelliere Nass
• Asbestos
• longshoremen

A $10.3 million verdict was secured against two stevedoring companies and a shipping company on behalf of Henry Pete, who was exposed to raw asbestos he unloaded from the Port Read More

• posted: Nov. 06, 2020
• Nass Cancelliere Nass
• Asbestos

While the dangerous presence of asbestos and asbestos exposure has long been associated with shipbuilders, sailors, construction workers, auto mechanics and other heavy industrial areas, there are other less-visible occupational Read More

• posted: Nov. 02, 2020
• Nass Cancelliere Nass
• Asbestos-Related Illnesses,  Asbestos
• Pennsylvania schools

In October of this year, three former or current school officials in Pennsylvania faced criminal charges due to allegations of hiding asbestos issues in the Scranton school district. NBC 10 Read More

• posted: Oct. 22, 2020
• Nass Cancelliere Nass
• Mesothelioma,  Asbestos
• asbestos litigation,  malignant mesothelioma,  mesothelioma lawsuits

KCIC, a respected Washington, D.C. consulting firm, published its annual report on mesothelioma and litigation recently. Of significance in the report is the fact that lawsuits filed by those diagnosed with Read More

• posted: Oct. 15, 2020
• Nass Cancelliere Nass
• Asbestos
• lawsuit,  ovarian cancer

Growing litigation over the fact that asbestos-contaminated talc was found in one of its products, Johnson and Johnson has to pay more than $100 million to settle more than 1,000 Read More

• posted: Oct. 09, 2020
• Nass Cancelliere Nass
• Mesothelioma,  Asbestos
• mesothelioma lawsuits,  mesothelioma verdicts,  personal injury lawsuit,  wrongful death lawsuit

According to industry reports, there were some 4,000 mesothelioma lawsuits filed in the U.S. last year. These suits fall into two categories: Personal Injury suits are typically filed by a person Read More

• posted: Oct. 01, 2020
• Nass Cancelliere Nass
• Mesothelioma,  Asbestos
• immunotherapy,  Ultimovacs,  UV1,  UV1 vaccine

A cancer vaccine that has already demonstrated effectiveness when used on malignant melanoma, prostate cancer and lung cancer in studies will be tested on mesothelioma patients. The novel UV1 vaccine, Read More

• posted: Sep. 24, 2020
• Nass Cancelliere Nass
• Mesothelioma,  Asbestos
• mesothelioma,  American Cancer Society,  asbestos attorney

​According to the American Cancer Society, caregiver is defined “… as the person who most often helps the person with cancer and is not paid to do so. In most cases, Read More

• posted: Sep. 18, 2020
• Nass Cancelliere Nass
• Mesothelioma,  Asbestos
• coronavirus,  COVID-19,  oncCOVID

Due to the COVID-19 pandemic, oncologists have had to balance patients' need for treatment with the risk of contracting the disease, sometimes prompting them to adjust standard treatment and/or rethink Read More

• posted: Sep. 10, 2020
• Nass Cancelliere Nass
• Asbestos
• mesothelioma,  malignant mesothelioma,  asbestos victims,  EPA

Since the 1970s, mesothelioma groups have urged the EPA to ban asbestos, citing the link between the substance and malignant mesothelioma and other illnesses. Still, the agency has not banned Read More

• posted: Aug. 27, 2020
• Nass Cancelliere Nass
• Mesothelioma,  Asbestos

Here’s what The American Cancer Society reports: For those who are diagnosed with mesothelioma and for their loved ones, it’s comforting to know that “scientists are looking for better ways to prevent, Read More